Skift Take: ClubMed’s revenue rose less than 5% last year, suggesting that “premiumization” isn’t delivering pricing power yet. An IPO would generate capital that might help fix that.
Skift Take: ClubMed’s revenue rose less than 5% last year, suggesting that “premiumization” isn’t delivering pricing power yet. An IPO would generate capital that might help fix that.